HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Type I Pituitary Adenylate Cyclase-Activating Polypeptide Receptors

A pituitary adenylate cyclase-activating peptide receptor subtype that is found in the HYPOTHALAMUS; BRAIN STEM; PITUITARY GLAND; ADRENAL GLAND; PANCREAS; and TESTES and has a high affinity only for PACAP.
Also Known As:
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; PAC1 Receptor; PACAP Type I Receptor; PACAPR-1 Protein; PACAPR 1 Protein; Pituitary Adenylate Cyclase Activating Peptide Receptor Type I; PACAP Receptors, Type I; Pituitary Adenylate Cyclase-Activating Peptide Receptor Type I
Networked: 31 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Experts

1. May, Victor: 3 articles (09/2014 - 11/2008)
2. Braas, Karen M: 3 articles (09/2014 - 11/2008)
3. Arranz, Alicia: 3 articles (07/2006 - 01/2002)
4. Gomariz, Rosa P: 3 articles (07/2006 - 01/2002)
5. Abad, Catalina: 3 articles (07/2006 - 01/2002)
6. Leceta, Javier: 3 articles (07/2006 - 01/2002)
7. Hammack, Sayamwong E: 2 articles (09/2014 - 02/2011)
8. Ressler, Kerry J: 2 articles (01/2013 - 02/2011)
9. Juarranz, Yasmina: 2 articles (07/2006 - 05/2005)
10. Martínez, Carmen: 2 articles (07/2006 - 05/2005)

Related Diseases

1. Septic Shock (Toxic Shock Syndrome)
2. Abnormal Reflex (Hyperreflexia)
3. Hypoglycemia (Reactive Hypoglycemia)
4. Post-Traumatic Stress Disorders (PTSD)
5. Migraine Disorders (Migraine)

Related Drugs and Biologics

1. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)
2. Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
3. Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
4. Fibrinogen (Factor I)
5. Pituitary Adenylate Cyclase-Activating Polypeptide Receptors
6. Nitric Oxide (Nitrogen Monoxide)
7. Insulin (Novolin)
8. Glucagon (Glukagon)
9. Cyclophosphamide (Cytoxan)
10. Serum Amyloid A Protein (Serum Amyloid A)

Related Therapies and Procedures

1. Intensive Care (Surgical Intensive Care)
2. Therapeutics